Abstract
This study examined the effects of acute administration of delta-9-tetrahydrocannabinol (Δ9-THC), the psychoactive ingredient in marijuana, on extracellular efflux of dopamine (DA) and its metabolites as measured by in vivo microdialysis in nucleus accumbens of conscious, freely-moving rats. Δ9-THC, at low doses (0.5–1.0 mg/kg), which significantly enhance brain stimulation reward (intracranial self-stimulation), significantly increased DA efflux in nucleus accumbens. Augmentation of DA efflux by Δ9-THC was abolished by removal of calcium (Ca++) ions from the perfusion fluid, indicating a Ca++-dependence of Δ9-THC's action. Augmentation of DA efflux by Δ9-THC was either totally blocked or significantly attenuated by doses of naloxone as low as 0.1 mg/kg. Given the postulated role of mesocorticolimbic DA circuits in mediating and/or modulating brain stimulation reward, the present data raise the possibility that marijuana's rewarding effects, and hence its euphorigenic effects and abuse potential, may be related to pharmacological augmentation of presynaptic DA mechanisms. Additionally, the DA mechanisms enhanced by marijuana appear to be modulated by an endogenous opioid peptide system.
Similar content being viewed by others
References
Banerjee SP, Snyder SH, Mechoulam R (1975) Cannabinoids: influences on neurotransmitter uptake in rat brain synaptosomes. J Pharmacol Exp Ther 194:74–81
Bloom AS (1982) Effect of delta-9-tetrahydrocannabinol on the synthesis of dopamine and norepinephrine in mouse brain synaptosomes. J Pharmacol Exp Ther 221:97–103
Bozarth MA, Wise RA (1981) Intracranial self-administration of morphine into the ventral tegmental area of rats. Life Sci 28:551–555
Bozarth MA, Wise RA (1986) Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement. NIDA Res Monogr Ser 67:190–196
Carboni E, Imperato A, Perezzani L, Di Chiara G (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28:653–661
Di Chiara G, Imperato A (1986) Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats. Ann NY Acad Sci 473:367–381
Di Chiara G, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067–1080
Esposito RU, Kornetsky C (1978) Opioids and rewarding brain stimulation. Neurosci Biobehav Rev 2:115–122
Esposito RU, Perry W, Kornetsky C (1980) Effects ofd-amphetamine and naloxone on brain stimulation reward. Psychopharmacology 69:187–191
Gardner EL, Zukin RS, Makman MH (1980) Modulation of opiate receptor binding in striatum and amygdala by selective mesencephalic lesions. Brain Res 194:232–239
Gardner EL, Paredes W, Smith D, Donner A, Milling C, Cohen D, Morrison D (1988) Facilitation of brain stimulation reward by Δ9-tetrahydrocannabinol. Psychopharmacology 96:142–144
Gardner EL, Paredes W, Smith D, Zukin RS (1989) Facilitation of brain stimulation reward by Δ9-tetrahydrocannabinol is mediated by an endogenous opioid mechanism. Adv Biosci 75:671–674
Glantz MD (ed) (1984) Correlates and consequences of marijuana use (ADAMHA Research Issues no. 34). Alcohol, Drug Abuse, and Mental Health Administration, US Public Health Service, Rockville, MD
Goeders NE, Smith JE (1983) Cortical dopaminergic involvement in cocaine reinforcement. Science 221:773–775
Goeders NE, Lane JD, Smith JE (1984) Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol Biochem Behav 20:451–455
Hernandez L, Hoebel BG (1988) Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci 42:1705–1712
Hershkowitz M, Szechtman H (1979) Pretreatment with Δ1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior. Eur J Pharmacol 59:267–276
Hoebel BG, Monaco AP, Hernandez L, Aulisi EF, Stanley BG, Lenard L (1983) Self-injection of amphetamine directly into the brain. Psychopharmacology 81:158–163
Illes P (1986) Mechanisms of receptor mediated modulation of transmitter release in noradrenergic, cholinergic and sensory neurons. Neuroscience 17:909–928
Imperato A, Di Chiara G (1986) Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 239:219–228
Johnson KM, Dewey WL, Harris LS (1976) Some structural requirements for inhibition of high-affinity synaptosomal serotonin uptake by cannabinoids. Mol Pharmacol 12:345–352
Kalén P, Strecker RE, Rosengren E, Björklund A (1988) Endogenous release of neuronal serotonin and 5-HIAA in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high performance liquid chromatography with fluorimetric detection. J Neurochem 51:1422–1435
Kirk, RE (1982) Experimental design, 2nd edn. Brooks/Cole, Monterey, CA
Kornetsky C (1985) Brain-stimulation reward: a model for the neuronal bases for drug-induced euphoria. NIDA Res Monogr Ser 62:30–50
Kornetsky C, Esposito RU, McLean S, Jacobson JO (1979) Intracranial self-stimulation thresholds. Arch Gen Psychiatry 36:289–292
Lorens SA, Sainati SM (1978) Naloxone blocks the excitatory effect of ethanol and chlordiazepoxide on lateral hypothalamic self-stimulation behavior. Life Sci 23:1359–1364
Lyness WH, Friedle NM, Moore KE (1979) Destruction of dopaminergic nerve terminals in nucleus accumbens: effect ond-amphetamine self-administration. Pharmacol Biochem Behav 11:553–556
Nazzaro JM, Seeger TF, Gardner EL (1980) Naloxone blocks phencyclidine's dose-dependent effects on direct brain reward thresholds. In: Proceedings of World Conference on Clinical Pharmacology and Therapeutics. British Pharmacological Society, London, p 949
Nazzaro JM, Gardner EL, Bridger WH, Carlson KR, Seeger TF (1981) Pentobarbital induces a naloxone-reversible decrease in mesocorticolimbic self-stimulation thresholds. Soc Neurosci Abstr 7:262
Ng Cheong Ton JM, Gerhardt GA, Friedemann M, Etgen AM, Rose GM, Sharpless NS, Gardner EL (1988) Effects of Δ9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study. Brain Res 451:59–68
Paredes W, Chen J, Gardner EL (1989) A miniature microdialysis probe: a new simple construction method for making a chronic, removable and recyclable probe. Curr Separations 9:94
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, Sydney, Australia
Petersen RC (ed) (1980) Marijuana and health: 8th annual report to the US Congress from the Secretary of Health and Human Services. National Institute on Drug Abuse, US Public Health Service, Rockville, MD
Phillips AG, Mora F, Rolls ET (1981) intracerebral self-administration of amphetamine by rhesus monkeys. Neurosci Lett 24:81–86
Poddar MK, Dewey WL (1980) Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes. J Pharmacol Exp Ther 214:63–67
Roberts DCS, Corcoran ME, Fibiger HC (1977) On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 6:615–620
Rosenkrantz H, Sprague RA, Fleischman RW, Brude MC (1975) Oral Δ9-tetrahydrocannabinol toxicity in rats treated for periods up to 6 months. Toxicol App Pharmacol 32:399–417
Sakurai Y, Ohta H, Shimazone T, Kataoka Y, Fujiwara M, Ueki S (1985) Delta-9-tetrahydrocannabinol elicits ipsilateral circling behavior in rats with unilateral nigral lesion. Life Sci 37:2181–2185
Sharp T, Maidment NT, Brazell MP, Zetterström T, Ungerstedt U, Bennett GW, Marsden CA (1984) Changes in monoamine metabolites measured by simultaneous in vivo differential pulse voltammetry and intracerebral dialysis. Neuroscience 12:1213–1221
Spyraki C, Fibiger HC, Phillips AG (1983) Attenuation of heroin reward in rats by disruption of the mesocorticolimbic dopamine system. Psychopharmacology 79:278–283
Vaysse PJ-J, Gardner EL, Zukin RS (1987) Modulation of rat brain opioid receptors by cannabinoids. J Pharmacol Exp Ther 241:534–539
Westerink BH, Tuntler J, Damsma G, Rollema H, de Vries JB (1987) The use of tetrodotoxin for the characterization of drugenhanced dopamine release in conscious rats studied by brain dialysis. Naunyn Schmiedeberg's Arch Pharmacol 336:502–507
Winer BJ (1962) Statistical principles in experimental design. McGraw-Hill, New York
Wise RA (1980) Action of drugs of abuse on brain reward systems. Pharmacol Biochem Behav [Suppl 1] 13:213–223
Wise RA (1982) Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 25:39–87
Wise RA (1984) Neural mechanisms of the reinforcing action of cocaine. NIDA Res Monogr Ser 50:15–33
Wise RA, Bozarth MA (1984) Brain reward circuitry: four circuit elements “wired” in apparent series. Brain Res Bull 12:203–208.
Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469–492
Wise RA, Rompre P-P (1989) Brain dopamine and reward. Annu Rev Psychol 40:191–225
Yokel RA, Wise RA (1975) Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science 187:547–549
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, J., Paredes, W., Li, J. et al. Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 102, 156–162 (1990). https://doi.org/10.1007/BF02245916
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245916